Hans van Houte

Chief Financial Officer, Nurix Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.6M

Companies

Latest trade

Aug 4, 2026

Companies

Nurix Therapeutics, Inc.Chief Financial Officer −$0.6M

Trades

NRIX Sold 4,761 shares at $24.36 · planned $0.1M Aug 4

NRIX Sold 2,845 shares at $23.38 $0.1M Jul 30

NRIX Sold 14,055 shares at $16.60 · planned $0.2M May 5

NRIX Sold 2,388 shares at $16.65 $0.0M Apr 30

NRIX Sold 3,661 shares at $16.60 $0.1M Jan 30

NRIX Sold 6,284 shares at $12.56 · planned $0.1M Nov 3

NRIX Sold 3,130 shares at $12.80 $0.0M Oct 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.